Insight

Francisco J. Esteva: The NeoSTEEP initiative

Photo of Francisco J. Esteva/LinkedIn

Aug 12, 2024, 12:38

Francisco J. Esteva: The NeoSTEEP initiative

Lenox Hill Hospital shared a post on LinkedIn:

“The NeoSTEEP initiative provides critical standardized definitions for efficacy endpoints in neoadjuvant breast cancer trials, ensuring the comparability of trial results.

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

Authors: Jennifer K Litton, Meredith M Regan, Lajos Pusztai, Hope S Rugo, Sara M Tolaney, Elizabeth Garrett-Mayer, Laleh Amiri-Kordestani, Reva K Basho, Ana F Best, Jean-Francois Boileau, Carsten Denkert, Jared C Foster, Nadia Harbeck, Heather A Jacene, Tari A King, Ginny Mason, Ciara C O’Sullivan, Tatiana M Prowell, Andrea L Richardson, Karla A Sepulveda, Mary Lou Smith, Judy A Tjoe, Gulisa Turashvili, Wendy A Woodward, Lynn Pearson Butler, Elena I Schwartz, and Larissa A Korde.

Source:

cancer Elena I Schwartz Francisco J. Esteva Jennifer K Litton Lajos Pusztai Larissa A Korde Lenox Hill Hospital Lynn Pearson Butler Meredith M Regan NeoSTEEP OncoDaily Oncology

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage